AUAUniversity cover art

All Episodes

AUAUniversity — 446 episodes

#
Title
1

Update Series (2026) Lesson 18: Testosterone Therapy: Is It Safe? A Case-Based Approach

2

AUA Guidelines: Advanced Prostate Cancer

3

AUA2026: Focus on: Metastatic Urothelial Carcinoma (mUC)

4

AUA Guidelines: Clinically Localized Prostate Cancer

5

Update Series (2026): Kidney Stones and the Infected Patient

6

AUA2026: Focus on: Biomarkers, MRI and PSMA PET Imaging in Prostate Cancer Webcast

7

AUA2026 Spotlight: PARP-Inhibitor Combination Treatments for the Urologic Care Team

8

Update Series (2026) Lesson 15: Case-Based Testicular Cancer Clinical Practice Guidelines

9

AUA Guidelines: Management of Lower Urinary Tract Symptoms Attributed to BPH

10

AUA2026: Society of Women in Urology Meeting

11

AUA2026: Society of Urologic Oncology Meeting

12

AUA2026: Society of Benign Prostate Disease Meeting

13

AUA Guidelines: Early Detection of Prostate Cancer

14

AUA2026: Sexual Medicine Society of North America Meeting

15

AUA2026: Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) Meeting

16

Update Series (2026): At-Home Diagnostic and Therapeutic Options in Men's Health

17

AUA2026: Research Programming Preview: Amplifying the Impact of Research for Career Development

18

Update Series (2026): Perioperative Management of Urinary Diversion

19

AUA2026: Advanced Cystoscopy Training for APPs

20

LG-IR-NMIBC Treatment Landscape (Republished)

21

NMIBC Treatment Landscape (Republished)

22

MIBC Treatment Landscape (Republished)

23

AUA2025: Key Takeaways: Bladder Cancer

24

Update Series (2026) Lesson 5: Long-term Urinary Catheters: Their Role & Management of Complications

25

Adjuvant Therapy for Renal Cell Carcinoma

26

Use of Suction Ureteroscopes for Kidney Stone Treatment: CVAC System

27

Update Series: The Role of Nephrectomy in Advanced Kidney Cancer

28

AI for Prostate Cancer Treatment Planning

29

AUA Guidelines: Salvage Therapy for Prostate Cancer

30

AUA Guidelines: Diagnosis and Management of Male Chronic Pelvic Pain

31

NMIBC Treatment Landscape

32

MIBC Treatment Landscape

33

AUA Guidelines: Genitourinary Syndrome of Menopause

34

LG-IR-NMIBC Treatment Landscape

35

Core Curriculum: Surgical Management of Urolithiasis

36

AUA2025: Key Takeaways: BPH

37

AUA2025: Key Takeaways: Lower Urinary Tract Reconstruction

38

AUA Guidelines: Recurrent Uncomplicated Urinary Tract Infections in Women

39

Core Curriculum: Anorectal Malformation

40

AUA2025: Key Takeaways: Endourology/Stones Highlights

41

Update Series (2025) Lesson 30: Beyond Ureteropelvic Junction: Case-Based Tips and Tricks in Robotic Ureteral Stricture Reconstructive Surgery

42

The Latest Breakthroughs in LG-IR-NMIBC (2025)

43

The Latest Breakthroughs in mHSPC

44

AUA2025: Key Takeaways: Sexual Dysfunction Highlights

45

AUA2025: Key Takeaways: Female Urology Highlights

46

AUA2025: John Duckett Memorial Lecture: Obstructive Bladder Disease: Molecular Insights and Therapeutic Opportunities

47

AUA2025: Ramon Guiteras Lecture: The Future of Healthcare: How Will Urology be Impacted?

48

AUA2025: John K Lattimer Lecture: Telesurgery

49

Contemporary Management of MIBC and Beyond: Expert Guidance for Urologists (Republished)

50

AUA2025: Chemotherapy and Immunotherapy for Urologists and Advanced Practice Providers (APPs)

51

Update Series (2025) Lesson 18: Multidisciplinary Evaluation and Management of Pelvic Pain in Women

52

AUA2025: Incorporating Genomic Testing and Advanced Imaging for Prostate Cancer Into Your Practice

53

AUA2025: Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems

54

The Surgical Management of BPH (2025)

55

AUA2025: AUA Advanced Prostate Cancer Course

56

AUA2025: Should I Order a PET Scan? Integrating Molecular Imaging Into Urologic Oncology Clinical Practice: Current Approaches and Future Opportunities

57

AUA2025: AUA Guidelines on Early Detection of Prostate Cancer: Maximizing Benefits, Minimizing Harm

58

AUA2025: Genetics and Genomics of Urological Cancers - Current Guidelines and Case-based Discussion to Guide Clinical Practice

59

Highlights from AUA2025: Advances in NMIBC (2025)

60

AUA Guidelines: Microhematuria

61

AUA2025: Embracing Multi-Disciplinary Care for Advanced Prostate Cancer: A Case-Based Update 2025

62

AUA2025: Non-Muscle Invasive Bladder Cancer Treatment Dilemmas: The Cases You Face and How Best to Treat Them

63

AUA2025: Integration of Biomarkers, MRI and PSMA PET Imaging Into the Management of Prostate Cancer

64

AUA2025: PARP-Inhibitor Combination Treatments for the Urologic Care Team

65

Live from AUA2025: Advances in ADT Program

66

AUA2025: Sexual Medicine Society of North America Meeting

67

AUA2025: Society of Urological Robotic Surgeons Meeting

68

AUA2025: Focal Therapy Society Meeting

69

Update Series 2025: Congenitalism: Transitioning Patients with Congenital Urological Anomalies

70

AUA2025: Masterclass: Renal Access and Interventions (2025)

71

Hereditary Kidney Cancer Syndromes (Republished)

72

AUA2025: Fundamentals of Prostate MRI and Transperineal Interventions (2025)

73

Recognition and Management of Complications Following Gender Affirming Surgery

74

AUA Guidelines: Diagnosis and Treatment of Infertility in Men

75

AUA Guidelines: Diagnosis And Treatment Of Idiopathic Overactive Bladder

76

AUA Guidelines: Treatment Of Non - Metastatic Muscle - Invasive Bladder Cancer

77

Biomarkers and Molecular Imaging for Prostate Cancer (Republished)

78

Appropriate Use of Genetic Testing (Republished)

79

Treatment Intensification in Metastatic HSPC (Republished)

80

Sequencing Of Agents (Republished)

81

Non-Muscle Invasive Bladder Cancer: Expert Guidance for Urologists

82

Contemporary Management of MIBC and Beyond: Expert Guidance for Urologists

83

Complex Cases in Kidney Stone Disease

84

Update Series Lesson 39: Penile Duplex Doppler Ultrasound in the Evaluation of Sexual Dysfunction

85

AUA2024: Journal Of Urology Lecture

86

AUA2024: Ramon Guiteras Lecture

87

AUA Leadership and Business Podcast: Urology Practice Manage - Overcoming Operational Challenges

88

Core Curriculum: Focal Therapy Options for Prostate Cancer

89

Hereditary Kidney Cancer Syndromes

90

Prostate Cancer Update (2024): Expert Guidance for Urologists

91

Treatment Intensification in Metastatic HSPC

92

Appropriate Use of Genetic Testing (who, what, when and how?)

93

Sequencing Of Agents

94

Core Curriculum: Urologic Oncology: Genetics And Genomics

95

Biomarkers and Molecular Imaging for Prostate Cancer

96

Core Curriculum: Kidney Cancer & SBRT in the Management of RCC

97

Core Curriculum: Pediatric Urology: Differences of Sex Development

98

AUA2024:How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients

99

AUA2024: The Changing Face of Advanced Prostate Cancer

100

Update Series (2024) Lesson 6: AUA Localized Renal Mass Guidelines Update

101

AUA2024: Prostate Cancer Diagnosis

102

AUA2024: Incorporating Genomic Testing and Advanced Imaging For Prostate Cancer Into Your Practice

103

AUA2024: Upper Tract Urothelial Cancer (UTUC) Guidelines

104

The Surgical Management of BPH and Updates from the AUA Clinical Guidelines

105

AUA2024: New AUA Guideline: Salvage Therapy for Prostate Cancer

106

AUA2024: Genetics and Genomics of Urological Cancers

107

AUA2024: Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems

108

AUA2024: Contemporary Pharmacotherapy for OAB 2024

109

AUA2024: AUA Advanced Prostate Cancer Guidelines

110

Live from AUA2024: Highlights in Bladder Cancer

111

AUA2024: Upper Tract Urothelial Carcinoma Tumor Board: A Case-Based Approach to Management

112

AUA2024: Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider

113

AUA2024: Practical Implementation of Third-Line Therapies for Refractory Overactive Bladder

114

AUA2024: Genetics and Genomics of Urological Cancers

115

Core Curriculum: Journal Club 101

116

Core Curriculum: BPH: Surgical Treatment

117

AUA2024: Surgical Laser Enucleation of the Prostate

118

AUA2024: A Specialized Masterclass for Single-port Robot-Assisted Surgery

119

Update Series (2024) Lesson 1: A Case-Based Discussion of Priapism Guidelines

120

AUA2023 Take Home Messages Part 5

121

AUA2023 Take Home Messages Part 3

122

AUA2023 Take Home Messages Part 4

123

AUA2023 Take Home Messages Part 2

124

AUA2023 Take Home Messages Part 1

125

PARPi: Management of Adverse Events

126

AUA2023 Journal of Urology Lecture

127

AUA2023 Ramon Guiteras Lecture

128

AUA2023 John Duckett Memorial Lecture

129

AUA2023 John K. Lattimer Lecture

130

Adjuvant Therapies for High-Risk Non-Metastatic Kidney Cancer

131

The Latest Breakthroughs in Immunotherapy for GU Cancers

132

Germline Testing and Novel Approaches to Targeting Genetic Mutations in Prostate Cancer

133

Novel Imaging for Genitourinary Cancers - Diagnostics and Theranostics

134

Early Detection of Prostate Cancer: AUA/SUO Guideline (2023)

135

Treatment Paradigms for Intermediate and High-Risk Non-Muscle Invasive Bladder Cancer

136

PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test

137

Infectious Complications Following Prostate Biopsy

138

Germline Testing in GU Cancers – How I Do It

139

Treatment Intensification for Advanced Prostate Cancer

140

PARPi: Precision Medicine in Advanced Prostate Cancer

141

Prostate Cancer Treatment Intensification

142

Update Series (2023) Lesson 33: A Critical Appraisal of the 2021 AUA/SUFU Guideline

143

Disparities in Care and Barriers to Access for Patients with Advanced Prostate Cancer

144

Systemic Therapies for Advanced Prostate Cancer – Short and Long-Term Side Effects

145

Genetic Testing and Stone Disease

146

Advances in ADT Part II: A Guide for Urologists

147

Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice

148

AUA2023 Medical Student Forum

149

AUA2023: Managing Toxicities of Checkpoint Inhibitors: A Urologist’s Guide

150

AUA2023: How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients

151

Treatment for Hormone Sensitive Prostate Cancer

152

Update Series (2023) Lesson 21: Management of Chronic Pelvic Pain in Men

153

AUA2023: Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider

154

AUA2023: Upper-Tract Urothelial Cancer Guidelines

155

AUA2023: What the General Urologist Should Know about Care of Transgender Patients

156

AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes

157

AUA2023: Prostate Cancer Diagnosis

158

Global Advancements in Bladder Cancer

159

AUA2023: Advancing Gender Equity in Urology: Allyship for Men and Advocacy for Women

160

AUA2023: Genetics and Genomics of GU Malignancies: Applications into Your Clinical Practice

161

AUA2023: AUA Guidelines on Advanced Prostate Cancer

162

AUA2023: Diversity, Equity and Inclusion in Urology: What Do We Need to Know

163

AUA2023: The Changing Face of Advanced Prostate Cancer

164

AUA2023: Contemporary Pharmacotherapy for OAB 2023

165

Live from AUA2023: Highlights in BPH

166

Live from AUA2023: Highlights in Advanced Prostate Cancer

167

The Role of PARP Inhibitors in Advanced Prostate Cancer

168

AUA2022: Complications of Vaginal Mesh

169

AUA2022: An Evidence-based Approach to Primary Hypospadias Repair

170

Core Curriculum: Transitional Urology

171

Update Series (2023) Lesson 4: Difficult Foleys and Foley Difficulties

172

AUA2022: Evaluation and Management of Priapism

173

Organizational Leadership: How to Get Involved

174

Modernizing Urology Care: The Current and Future State of Virtual Care in the United States

175

Health Equities and Variations in Advanced Prostate Cancer Care

176

Comorbid Conditions in the Patient with Advanced Prostate Cancer

177

Advances in ADT: A Guide for Urologists and APPs

178

AUA2022 JU Lecture: Engaging Patients: A Challenge to our Care Delivery and Research Priorities

179

AUA2022 Ramon Guiteras Lecture: How to Reach Excellence in Urology: Challenges and Opportunities

180

AUA2022 John Duckett Memorial Lecture: Lifelong Learning, What’s in it for me?

181

AUA2022 John K. Lattimer Lecture: Testosterone, Science and Human Dignity

182

AUA2022 Presidential Address

183

PARP Inhibitors in Advanced Prostate Cancer Care

184

Advancing Women in Urology: Sponsorship and Its Role in Career Advancement in Medicine

185

Addressing Disparities and Variations in Care in GU Oncology

186

Advancing Women in Urology: Coaching and Self-Advocacy

187

Advancing Women in Urology: Negotiating for Success

188

Advanced Kidney Cancer: A Guide to Targeted Agents and Immunotherapies

189

Advancing Women in Urology: The Importance of Meaningful Mentorship

190

Urothelial Carcinoma: Advances in Immuno-Oncology

191

Appropriate use of Biomarker and Genetic Testing in the Diagnosis and Management of Patients

192

Novel Imaging for Genitourinary Cancers

193

Systemic Therapies for mHSPC and Castrate Resistant Prostate Cancer

194

Update Series (2022) Lesson 7: Management of BPH in Men >80 Years

195

Application of the Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline in Clinical Practice

196

Negotiating Skills 101: Key Steps To Becoming A Good Negotiator

197

Primary Palliative Care in Urology

198

Core Curriculum: Stress Urinary Incontinence Surgery (Female)

199

Cultural Barriers for Ethnic Minorities

200

Core Curriculum: Geriatric Oncology

201

Update Series: Asymptomatic Bacteriuria, Atypical Urinary Tract Infection & the Urinary Microbiome

202

Core Curriculum: GU Cancer Survivorship

203

Advancing Equitable Opportunities for Recruitment of Diverse Patients to Clinical Trials

204

Core Curriculum: Urolithiasis – Surgical Management

205

Core Curriculum: Feminizing and Masculinizing Genital Gender Affirming Surgery

206

AUA2022: Diagnosis And Management Of Localized, Locally Advanced And Advanced Kidney Cancer

207

AUA2022: Operationalizing Checkpoint Inhibitors In Urologic Practice

208

Financial Toxicity as Drugs Move Earlier into Treatment Paradigm

209

AUA2022: Incorporating Genomic Testing For Prostate Cancer Into Your Practice

210

AUA2022: Refractory Overactive Bladder: How to Select 3rd-Line Therapies and Optimize Outcomes

211

AUA2022: Bladder Cancer Treatment Dilemmas: The Cases You Face and What To Do about Them

212

AUA2022: Genetic Testing in Prostate Cancer Webcast

213

Surgical Implications For LGBTQ Patients

214

AUA2022: Surgical & Medical Management of High-Risk Renal Cell Carcinoma

215

AUA2022: Contemporary Pharmacotherapy for OAB 2022

216

Controversies, Confusion, and the Future of Urologic Post-Operative Opioid Prescribing Strategies

217

AUA2022: Difficult Cases in High-Risk Bladder Cancer: An Evidence-Based Approach

218

AUA2022 : The Changing Face of Advanced Prostate Cancer 2022

219

Update Series: AUA/ASRM Infertility Guideline Critique

220

AUA2022: Diversity Equity and Inclusion in Urology: What Do We Need to Know?

221

AUA2022: Should I Order a PET Scan?

222

Live from AUA2022: Highlights in BPH

223

Live from AUA2022: Highlights in Advanced Prostate Cancer

224

Live from AUA2022: Highlights in Overactive Bladder

225

Publishing Ethics

226

Publishing Ethics

227

Adolescent and Young Adult (AYA) Oncology Focusing on Translocation RCC

228

Global Advancements in Prostate Cancer: The Role of Genetic Testing and PARP Inhibitors

229

New Minimally Invasive BPH Treatment Options

230

Global Advancements in Prostate Cancer: Best Practices in Hormonal Therapy

231

Update Series: Conscious Sedation in the Urology Office

232

Prostate Biopsy: The Transperineal vs. Transrectal Debate

233

AUA2021 State-Of-The-Art Lecture First & Second Line Therapy In Advanced & Metastatic Bladder Cancer

234

AUA2021 State-Of-The-Art Lecture: Penile Fracture Causes And Management

235

AUA2021 Panel Discussion: The Future Of Urologic Oncology

236

AUA2021 State-Of-The-Art Lecture: Robotic Ureteroscopy

237

AUA2021 Panel Discussion: Artificial Intelligence Applications In Urology

238

AUA2021 State-Of-The-Art Lecture: Pain Management In FPMRS Surgery

239

AUA2021 Panel Discussion: COVID And Sexual Medicine

240

AUA2021 John Duckett Memorial Lecture: Nephron Sparing Surgery In The Management Of Wilms Tumor

241

AUA2021 Journal Of Urology Lecture - The Promises And Pitfalls Of Large Database Studies

242

AUA2021 Ramon Guiteras Lecture - Three Decades Of Bladder Cancer Treatment: Progress And Promise

243

AUA2021 John K. Lattimer Lecture - Kidney Stones: Is Prevention Possible?

244

Testis Cancer – Apply the Guidelines to Clinical Practice

245

How to Safely and Properly Administer Immunotherapies

246

Management of Advanced Kidney Cancer: A Guide to Targeted Agents and Immunotherapies

247

Peer-Reviewed Guidance on How to Manage Immune-Related Adverse Events & Toxicities

248

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline Update

249

How Can We Improve SDM A Prostate Cancer Survivor’s Perspective

250

Novel Imaging for High Risk Prostate Cancer

251

Evolving Landscape of Androgen Deprivation Therapy in Advanced Prostate Cancer

252

Identification And Management Of Comorbid Conditions In The Patient With Advanced Prostate Cancer

253

Case Based Discussion: Role of Genetic Testing and End of Life Care

254

Optimizing the Treatment of Complicated UTIs

255

Case Based Discussion: Early M1 CRPC & Advanced M1 CRPC

256

Advances in Immuno-Oncology in Urothelial Carcinoma

257

Case Based Discussion: BCR and Novel Pet Imaging & M0 CRPC

258

Understanding Intrarenal Pressure

259

Live from AUA2021: Highlights in Overactive Bladder (2021)

260

Live from AUA2021: Highlights in Advanced Prostate Cancer (2021)

261

NMIBC Guidelines

262

Improving Racial Disparities in Treatment Outcomes Podcast

263

Urolithiasis: Metabolic Evaluation and Medical Management

264

Optimizing Pre-Operative Care for Patients Undergoing Urologic Surgery

265

Reducing Opioid Exposure in the Perioperative Setting

266

An Overview of PARPi & Adverse Event Management

267

Genomic Testing in Prostate Cancer

268

Insight into Race, SDM and the Impact on Access to Quality Care Podcast

269

Surgical Management Of BPH

270

Genetic Testing in Bladder Cancer

271

AUA2021 Kick Off Weekend: Contemporary Pharmacotherapy for OAB 2021

272

AUA2021 Kick Off Weekend: Chemotherapy and Immunotherapy for the Urologist and APP

273

AUA2021 Kick Off Weekend: Trimodality Therapy for Management of Muscle Invasive Bladder Cancer

274

AUA2021 Kick Off Weekend: Diagnosis & Management of Localized & Advanced Kidney Cancer

275

AUA2021 Kick Off Weekend: Incorporating Genomic Testing For Prostate Cancer into Your Practice

276

Diversity In Urology: Initiatives And Opportunities

277

How to Manage a 65 Year Old Man with Bothersome LUTS and Underactive Bladder

278

PARP Inhibitors: Best Practices In Advanced Prostate Cancer Care In The Community

279

Multidisciplinary Discussion On Fertility, Hypogonadism & Sexual Function For Testis Cancer Patients

280

PARP Inhibitors: Assessing the Clinical Trial Landscape

281

Controversies In Urology - Robotic Kidney Transplantation

282

Panel Discussion - Infection And Urologic Implants

283

PARP Inhibitors: Assessing the Rapidly Evolving Treatment Landscape

284

Metastatic Hormone Sensitive Prostate Cancer - Expert Guidance For Urologists

285

Impacts of COVID-19 on Urology Training and Education

286

Crossfire In Urology - Robotic Reconstruction

287

Adjuvant Treatment In Bladder Cancer

288

AUA Guidelines Case - Based Panel Stress Urinary Incontinence

289

Panel Discussion - Peyronie's Disease Management

290

Pain Management In Urologic Surgery

291

Bulbar Urethral Strictures 101 - A Review Of The Guidelines And Basic Management Options

292

Update Series - Dusting Vs Extraction Strategies During Ureteroscopy

293

GU Podcast (2020) - Sequencing Of Agents And Combination Of Treatment Options For RCC

294

GU Podcast (2020) - Sequencing Of Agents And Combination Of Treatment Options For Bladder Cancer

295

Role of Genetic Testing in Advanced M1 CRPC & M1 CRPC Post-Docataxel Chemotherapy

296

Case-Based Discussion: Early M1 CRPC Management and Advanced M1 CRPC

297

Case-Based Discussion: BCR and mHSPC & M0 CRPC

298

GU Podcast (2020): Genetic Testing And Personalized Medicine In Prostate Cancer

299

GU Podcast (2020): Addressing Disparities in Prostate Cancer Care

300

GU Podcast (2020): Chemo-ablation Of Upper-Tract Urothelial Carcinoma

301

GU Podcast (2020): Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline: Part 2

302

GU Podcast (2020): Targeted Therapies and Integration with Surgical Management of RCC

303

GU Podcast (2020): Immune Checkpoint Inhibitors In RCC

304

GU Podcast (2020): The Expanding Role Of Immune Checkpoint Inhibitors In MIBC And NMIBC

305

GU Podcast (2020): Advanced Prostate Cancer - AUA ASTRO SUO Guideline Podcast Part 1

306

Summer School - Urolithiasis Metabolic Evaluation & Medical Treatment Mixdown

307

Summer School: 2020 Guideline - BPH

308

Genetic Testing in Prostate Cancer: Considerations for Urologists and Their Patients

309

NIDDK Urologic Diseases In America Report - Urinary Stone Disease

310

Summer School: Controversies In Surgical Stone Management - A Case-Based Instructional Course

311

Summer School: Understanding The Evidence New Technologies For Treating BPH & LUTS 2020

312

Summer School : AUA 2020 Guideline Disorders Of Ejaculation

313

Summer School: Testis Cancer - Current Concepts And Controversies

314

Medical Student Curriculum Committee: Optimizing Interaction With Urology Remotely

315

Summer School: What General Urologists Can Do To Evaluate & Successfully Treat Male Infertility

316

Summer School: Current Urologic Management Of Female Sexual Dysfunction

317

Summer School: Recurrent UTIs In Women - Ask The Guideline

318

NIDDK Urologic Diseases In America Episode 3 - Benign Prostatic Hyperplasia

319

Summer School: Interstitial Cystitis/Bladder Pain Syndrome: Current Diagnosis and Management

320

Summer School: Surgical & Medical Management of Stones Guidelines Update

321

Chronic Orchialgia - An Algorithm For Successful Treatment

322

Increasing Workplace Diversity - Attracting And Retaining Women And Minority Urologists

323

Kidney Stone Disease: Rare and Challenging Cases

324

NIDDK Urologic Diseases in America Episode 2 - Urinary Incontinence

325

AUA2019 MAPPing The Clinical Implications Of Phenotypes And Clusters Mixdown

326

2020 AUA MIPS Reporting Webinar

327

COVID-19: Telemedicine with Dr. Eugene Rhee and Elective Surgery with Dr. Chris Gonzalez

328

AUA2019 Panel Discussion - New Technologies For Diagnosing UTIs

329

NIDDK Urologic Diseases In America Intro

330

AUA2019 State - Of - The - Art Lecture STDs And The CDC

331

Get The Facts : AUA/SUFU Diagnosis and Treatment Of Non-Neurogenic OAB in Adults Guideline Update

332

AUA2019 Crossfire: Controversies in Urology: Ureteral Reimplantation should be Robotic

333

AUA2019 Crossfire Controversies In Urology Primary Bulbar Stricture DVIU Is What To Do

334

Rotating On The Urology Service Facts And Strategy For Medical Students

335

2019 Presidential Address: Urologic Research: Why is it So Important to Us

336

AUA2018 Presidential Address: Artificial Intelligence, Robotics and the Future of Urology

337

AUA2017 Presidential Address: Urology: A Personal Perspective

338

AUA2016 Presidential Address: US Healthcare Reform: Past, Present, and Future

339

Targeted Therapies In Renal Cell Carcinoma

340

Sequencing Of Agents And Combination Of Treatment Options For Bladder Cancer

341

Sequencing Of Agents And Combination of Treatment Options for Renal Cell Carcinoma

342

Adjuvant Therapy in Renal Cell Carcinoma

343

Comorbidities in Advanced Prostate Cancer

344

Genetic Testing in Prostate Cancer

345

Chemo-ablation of Upper-Tract Urothelial Carcinoma

346

AUA SIU Symposium Therapeutic Advances In Immuno - Oncology

347

Immune Checkpoint Inhibitors In Renal Cell Carcinoma

348

AUA2019 Take Home Messages - Female Urology And Incontinence - Reconstruction

349

Sequencing Of Agents And Combination Therapy In Castrate Resistant Prostate Cancer

350

The Role of Immune Checkpoint Inhibitors in Bladder Cancer

351

Treatment For Metastatic Hormone Sensitive Prostate Cancer (M - HSPC)

352

Update Series v38l1 Diagnosis And Management Of Pheochromocytoma

353

Clinical Investigations in the Treatment of Urothelial Carcinoma

354

AUA2019 Take Home Messages Pediatrics

355

AUA2019 Take Home Messages Infertility Andrology - Sexual Dysfunction Mixdown

356

AUA2019 Take Home Messages - Endourology And Transplantation

357

AUA2019 Take Home Messages - Basic Sciences

358

Second Opinion Cases Ask The Guidelines! Recurrent Urinary Tract Infection

359

AUA2019 072IC Management Of NMIBC - Practical Solutions For Common Problems

360

Manipulating The Androgen Axis | Radionuclide Therapy And Bone Health

361

AUA2019 048IC Novel Agents & Concepts In The Management Of Hormone Naïve & CRPC

362

Setting Up a Clinic In The Community Setting | The Role Of Chemotherapy Treatment

363

AUA2019 037IC Help Patients Decide On Prostate Cancer Screening And Treatment

364

Genetic Testing in Advanced Prostate Cancer and Initial Management of Biochemical Recurrence

365

AUA2019 035IC Contemporary Pharmacotherapy For OAB 2019

366

AUA2019 077IC Establishing A Multidisciplinary Oncology Clinic With Advanced Therapeutics

367

AUA2019 027IC AUA CRPC Guidelines And Therapeutic Advances In Metastatic Prostate Cancer

368

AUA2019 023IC - Chemotherapy And Immunotherapy Options For Genitourinary Malignancies

369

AUA2019 076IC - Advanced OAB Therapies - What To Do When 1st And 2nd Line Therapies Do Not Work

370

AUA2019 013IC Genetic Testing In Prostate Cancer

371

Live From AUA2019 Management Of Advanced And Metastatic Urothelial Carcinoma

372

Live From AUA2019 Management Of Non - Muscle Invasive Urothelial Carcinoma

373

Medical Student Webinar: Urologic Care within Transgender Medicine: Overview of Core Knowledge

374

Framing Pragmatic Strategies To Reduce Mortality From Urothelial Cancer

375

Successful Utilization of Advanced Practice Providers in Urology Practice

376

Court is in Session: Benign: Opioid overdose in patient with chronic flank pain

377

AUA2018 Second Opinion Cases (ask the Guidelines!): Benign Prostatic Hyperplasia (BPH)

378

AUA2018 Second Opinion Cases Testosterone Deficiency

379

AUA2018 Second Opinion Cases Erectile Dysfunction

380

AUA2018 Take Home Messages Bladder Cancer - Basic Science Malignant

381

AUA2018 Take Home Messages Kidney Cancer & Transplantation

382

AUA2018 Take Home Messages Female Urology Incontinence - QIPS

383

AUA2018 Take Home Messages Prostate Cancer - BPH LUTS

384

AUA2018 Take Home Messages Penile Urethral Cancer - Outcomes

385

AUA2018 Take Home Messages Minimally Invasive Surgery - Imaging

386

AUA2018 Take Home Messages Pediatrics plus Highlights From SPU and Journal of Urology

387

Use of Novel Hormonal Agents and Systemic Therapy in Advanced Prostate Cancer Highlights (2018)

388

Immuno-Oncology: A Focus on Prostate Cancer

389

AUA2018 Residents Forum - The Evolving Practice Of Urology

390

AUA2018 Residents Forum - Wellness Burnout And Sustaining Your Career

391

Immuno-Oncology: A Focus on Kidney Cancer

392

Sequencing of Chemotherapy and Immunotherapy in Advanced Prostate Cancer Present and Future (2018)

393

Incorporating New IO Therapies - How to Properly Administer IO Therapies in an Infusion Suite

394

Immuno-Oncology: A Focus on Bladder Cancer

395

AUA2018 Residents Forum: Public Policy and Advocacy in Urology: A Primer for Residents

396

Incorporating New IO Therapies - Managing Patient Side Effects

397

Immuno - Oncoloy: A New Class Of Drugs

398

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer

399

Incorporating New IO Therapies - Biomarkers

400

Castration-Resistant Prostate Cancer (CRPC) Guideline Amendment

401

AUA2018 Take Home Messages - Infertility Andrology And Sexual Dysfunction

402

AUA2018 Take Home Messages - Endourology Stones - Infection Inflammation

403

Emerging Treatment Options For Non - Metastatic CRPC Sept 2018

404

Match Or Mismatch Presented by National Medical Student Education Committee

405

Emerging Treatment of M0 CRPC: Update on the AUA/SUO Guidelines

406

AUA2018 Take Home Messages Basic Sciences - Trauma

407

The Changing Landscape of Advanced Prostate Cancer Management: What You Need to Know

408

AUA2018 043IC - Novel Agents and Concepts in the Management of Hormone Naïve

409

AUA2018 078IC - Management of Prostate Cancer: A Case Based Approach

410

AUA2018 019IC: Immunotherapy for the Urologist: Basic Principles, Adverse Effects & Drug Delivery

411

AUA2018 063IC - Prostate Cancer Update

412

AUA2018 005IC - Chemotherapy and Immunotherapy Options for Genitourinary :A Primer for the APP

413

AUA2018 058IC - Management of Common Dilemmas in Prostate Cancer Diagnosis, Staging and Treatment

414

Highlights in Renal Cell Carcinoma: Coordination of Care & the Patient's Journey (2018)

415

AUA2018 031IC: Contemporary Pharmacotherapy for OAB

416

Focal Therapy Interview with John W. Davis, MD, FACS

417

Highlights in Renal Cell Carcinoma: The Evolving Landscape of Adjuvant Therapy (2018)

418

Highlights in Renal Cell Carcinoma: The Roles of the Urologist and Medical Oncologist (2018)

419

AUA2018 074IC - AUA CRPC Guidelines

420

AUA2018 Contemporary Pharmacotherapy for OAB

421

Minimally Invasive Treatment Of BPH

422

Update on Medical and Surgical Management of Advanced Testis Cancer

423

AUA2017 Court is in Session: Sepsis after Mini PNCL

424

CRPC Sequencing Agents

425

AUA CRPC Guidlines Overview

426

AUA2017 Court is in Session: Myocardial Infarction on Androgren Replacement Therapy

427

AUA2017: Court is in Session: Colostomy after Robotic Prostatectomy

428

AUA2017 Take Home Messages: Bladder Cancer - Transplantation - Female Urology

429

AUA2017 Take Home Messages: BPH/LUTS - Minimally Invasive Surgery - Quality

430

AUA2017 Take Home Messages: Pediatrics | Penile/Urethral Cancer | Kidney Cancer

431

AUA2017 Take Home Messages: Infertility/Andrology | Outcomes | Sexual Dysfunction

432

AUA2017 Take Home Messages: Prostate Cancer, Basic Sciences, and Trauma/Reconstruction

433

Bladder Cancer Immunotherapy Series: Complex Patient Cases

434

PSA Screening changes and USPSTF Recommendations

435

Bladder Cancer Immunotherapy Series: AUA Guideline

436

Low Testosterone

437

SUFU Clinical Care Pathway

438

Bladder Cancer Immunotherapy Series: Immunotherapy: From Research to Practice #1

439

Core Curriculum Video Abstract Request

440

Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer

441

Transgender; What Every Urologist Should Know

442

AUA Choosing Wisely

443

Shared Decision Making

444

CRPC 2016

445

Endourology

446

Female Sexual Dysfunction